NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

ATL, what you're saying is true. What's unknown is if the UK regulators after starting to work determined that they wanted RWD on everything that had been done with DCVax-L. That I believe would bring in information from all compassionate use done in the UK, and perhaps elsewhere. It might also bring in partially completed trials, like those being done at UCLA. In short it could bring the idea that this is a tumor agnostic vaccine into focus, whether NWBO initiated that kind of thinking, or not.

Gary